Lisa Hellström is an accomplished Clinical Program Director at Camurus, with extensive experience in clinical development, trial design, vendor management, and budget oversight, particularly in oncology, endocrinology, and rare diseases since September 2019. Prior to this, Lisa held various roles at Lundbeck, focusing on Alzheimer's disease drug development, including managing a major Phase III program involving numerous global studies and patient recruitment initiatives. Previous experience includes positions as Clinical Research Manager at Q-Med AB, and Clinical Research Associate at Merck Sharp & Dohme, specializing in asthma, osteoporosis, and rheumatology. Lisa holds a Master of Science in Pharmacy from Uppsala University.
This person is not in any teams
This person is not in any offices